Finepoint Capital LP Portfolio Holdings

Finepoint Capital LP

  • $963 Million
  • Q3 2024

Finepoint Capital LP has filed its 13F form on November 13, 2024 for Q3 2024 where it was disclosed a total value porftolio of $963 Million distributed in 26 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Liberty Broadband Corp with a value of $154M, Revolution Medicines, Inc. with a value of $33.2M, Argenx Se with a value of $29.5M, Ascendis Pharma A/S with a value of $28.4M, and Travere Therapeutics, Inc. with a value of $24.9M.

Examining the 13F form we can see an increase of $616M in the current position value, from $347M to 963M.

Finepoint Capital LP is based out at Boston, MA

Below you can find more details about Finepoint Capital LP portfolio as well as his latest detailed transactions.

Portfolio value $963 Million
ETFs: $554 Million
Healthcare: $255 Million
Communication Services: $154 Million
Financial Services: $22,000

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$11.4B
$154 Million 16.0% of portfolio
1,994,510
Q2 2024 Added 5.74%
$5B
$33.2 Million 3.44% of portfolio
731,960
Q3 2024 Added 0.34%
$32.7B
$29.5 Million 3.06% of portfolio
54,428
Q3 2024 Added 0.74%
$6.94B
$28.4 Million 2.95% of portfolio
190,072
Q3 2024 Added 0.42%
$1.15B
$24.9 Million 2.59% of portfolio
1,782,267
Q3 2024 Added 0.31%
$2.34B
$20.9 Million 2.17% of portfolio
650,852
Q3 2024 Added 1.96%
$1.82B
$19.6 Million 2.04% of portfolio
388,835
Q2 2024 Added 7.74%
$9.71B
$16.7 Million 1.73% of portfolio
133,535
Q3 2024 Added 0.53%
$1.69B
$16.1 Million 1.67% of portfolio
557,762
Q3 2024 Added 2.76%
$1.21B
$14.1 Million 1.47% of portfolio
574,378
Q2 2024 Added 6.54%
$2.63B
$13.9 Million 1.45% of portfolio
905,384
Q2 2024 Added 7.73%
$4.69B
$13.5 Million 1.41% of portfolio
256,449
Q2 2024 Added 7.73%
$560M
$11.5 Million 1.2% of portfolio
1,626,146
Q3 2024 Added 1.3%
$676M
$7.25 Million 0.75% of portfolio
433,471
Q2 2024 Added 7.72%
$305M
$5.65 Million 0.59% of portfolio
707,404
Q2 2024 Added 7.74%
Solid Biosciences Inc
-
$0 0.0% of portfolio
-
Q2 2023 Added 96.63%
Moneyhero Limited
-
$0 0.0% of portfolio
-
Q1 2024 New
$0
$22,000 0.0% of portfolio
735,000
Q4 2021 New
Lakeshore Biopharma CO LTD
-
$0 0.0% of portfolio
-
Q1 2023 New
$1.27M
$27,000 0.0% of portfolio
459,906
Q4 2021 New
-
$0 0.0% of portfolio
-
Q4 2021 New
Calidi Biotherapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 New
Qxo Inc
-
$0 0.0% of portfolio
-
Q3 2024 New

Summary

  • Portfolio
  • No. of Stocks 26
  • Current Value $963 Million
  • Prior Value $347 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 13, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 2 stocks
  • Additional Purchases 8 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Finepoint Capital LP Portfolio

Follow Finepoint Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Finepoint Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Finepoint Capital LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email